FormaPharm Engineering Group and Vimedimex 2 Pharmaceutical JSC have signed a consultancy contract that shall provide qualification and validation services for the project “Construction of a EU-GMP pharmaceutical manufacturing facility” that will produce Non-Betalactam drugs, Cephalosporin and Penicillin.
The contract stipulates provision of consulting, qualification and validation services related to design, procurement, construction and installation related to the pharmaceutical manufacturing facility that will comply with EU GMP standards. Total facility area is approximately 23000 square meters. Scheduled construction completion is March 2022.
Vimedimex2 has been established by the Vimedimex Group as a result of the patient demand to produce a cancer drug from local Vietnamese raw materials instead of importing. The newly established company aimed at providing 70% market share of cancer drug’s group L01, L02 in Vietnam, reducing 30% cost comparing to the imported one. Over nearly 30 years of operation in the field of pharmaceuticals, the VIMEDIMEX Group has achieved its purpose as a leading pharmaceutical distributor in Vietnam, creating a reputation for customers. Vimedimex Medical Joint Stock Company currently provides 70% of special medicines for hospitals across the country.